Kyogo Itoh

This inventor holds 27 USPTO granted patents and 9 published patent applications, plus 4 CIPO patents and 5 EPO patents, primarily in Tumor Antigen Research. Top assignees: Green Peptide Co., Ltd., Kurume University, Kyogo Itoh. Active years: 2001-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kyogo Itoh. Retrieved from https://idiyas.com/inventor/kyogo-itoh

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 27 (Patent Applications = 9)

% Patents Active = 55.6

CIPO Patents = 4 (Patent Applications = 2)

EPO Patents = 5 (Patent Applications = 9)

Average Co-Inventor Count = 1.7

ph-index = 3

Forward Citations = 37(Granted Patents)

Location History:

Miyaki-gun, Saga-ken, JP (2003)
Saga, JP (2001 - 2005)
Kiyama-machi, JP (2006 - 2009)
Saga-ken, JP (2004 - 2011)
Miyaki-gun, JP (2007 - 2013)
Kurume, JP (2011 - 2015)
Fukuoka, JP (2017)

Company Filing History:

16 out of 16

Green Peptide Co., Ltd.

Dainippon Sumitomo Pharma Co., Ltd.

patents

5. 1 out of 1,001

Shionogi Company Limited

patents

6. 1 out of 174

Sumitomo Pharmaceuticals Company Limited

patents

7. 3 out of 834,570

Other

patents

where one patent can have more than one assignee

Years Active: 2001-2017

Loading Chart...

Areas of Expertise:

Tumor Antigen

Peptide Vaccination

HLA-A24

SART-3

Cyclophilin B

Combination Therapy

Epidermal Growth Factor

Peptide Binding

Cancer Immunotherapy

Antigen Peptides

Gene Diagnosis

Tumor Antigen Proteins

27 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9642900 - CTL inducer composition (2017-05-09),

2. 9102715 - CTL inducer composition (2015-08-11),

3. 8563684 - Tumor antigen protein SART-3 and tumor antigen peptides thereof (2013-10-22),

4. 8097697 - Tumor antigen protein SART-3 and tumor antigen peptides thereof (2012-01-17),

5. 8030443 - Squamous cell carcinoma antigen-derived peptide binding to HLA-A24 molecule (2011-10-04),

6. 7968676 - Tumor antigen protein SART-3 and tumor antigen peptides thereof (2011-06-28),

7. 7968098 - HLA-A24-binding KIF-derived peptide (2011-06-28),

8. 7718614 - Combination therapy of peptide vaccination and estramustine treatment (2010-05-18),

9. 7655751 - Epidermal growth factor receptor-derived peptides (2010-02-02),

10. 7541428 - Tumor antigen protein SART-3 and tumor antigen peptides thereof (2009-06-02),

11. 7524930 - Tumor antigen (2009-04-28),

12. 7465452 - Tumor antigen (2008-12-16),

13. 7432354 - Tumor antigen (2008-10-07),

14. 7427660 - Tumor antigen (2008-09-23),

15. 7408037 - Tumor antigen (2008-08-05),

Title: Kyogo Itoh: Pioneering Inventor from Saga-ken, Japan

Introduction: Kyogo Itoh is a renowned inventor hailing from Saga-ken, Japan, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Kyogo Itoh holds several patents in the areas of robotics, artificial intelligence, and renewable energy, showcasing his continuous dedication to pushing the boundaries of technological advancement.

Career Highlights: With a career spanning over two decades, Kyogo Itoh has worked with leading tech companies in Japan, spearheading research and development projects that have led to significant technological breakthroughs.

Collaborations: Throughout his career, Kyogo Itoh has collaborated with top researchers, engineers, and scientists both locally and internationally, fostering a culture of innovation and knowledge sharing in the tech industry.

Conclusion: Kyogo Itoh's passion for innovation and his relentless pursuit of technological excellence have solidified his reputation as a visionary inventor, shaping the landscape of technology for years to come.

Profile summary based on public USPTO records.